Search

everythinglearnresearchcommunity

for

Search:↓

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Certain adrenal hormones can strongly stimulate oil gland growth in hamster skin, similar to male hormones.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

DHEA acts like a male hormone on rat skin glands and doesn't turn into female hormones there.

The compounds tested could potentially treat hair loss and alopecia.

Normal hair density and diameter ratios were established to help diagnose adult hair loss.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

Gene variation affects prostate issues and hair loss.

Testosterone affects androgen receptors and lipid storage in cells, while DHEA does not convert to testosterone or affect these receptors in the same way.

Minoxidil can reduce functions related to androgen receptors.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

Androgen therapy can help with symptoms like low libido in women, but more research is needed to understand its long-term safety and effects on health.

Dosing time affects finasteride's effectiveness and safety in rats.

TrichoScan helps identify subtle hair thinning in women with androgenetic alopecia.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Men with androgenetic alopecia have oilier and less hydrated scalps, especially in sensitive areas.

CEC levels may be a useful marker for predicting prostate cancer progression.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Acne severity in women with PCOS is linked to younger age, lower body weight, and more body hair, but not to hormone levels.

Male hormones are important for hair and oil gland development and can cause conditions like excessive hair growth and acne.

Male hormones, or androgens, affect women's health in areas like mood and bone density, and hormone replacement therapy using antiandrogenic progestogens can improve mood disorders and alertness in menopausal women.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Lowering testosterone speeds up wound healing in male mice.

Hidradenitis suppurativa improves with antiandrogen therapy.